Announcement of the second meeting of the fourth Board of Directors

release time:

2024-01-09 15:53

AnnouncementNumber: 2024-002

Stock code: 832316                      Securities abbreviation: Tim Zheng Biotech                 Host brokerage: Shenwan Hongyuan underwriting sponsor

 

Jilin Tianzheng Biotechnology Co., Ltd

Announcement of the second meeting of the fourth Board of Directors

 

The Company and all members of the Board of Directors warrant that the content of the announcement is true, accurate and complete, and there are no false records, misleading statements or material omissions, and assume individual and joint legal responsibility for the authenticity, accuracy and completeness of its content.

 

1. The convening and attendance of the meeting
(1) Information on the convening of the meeting
1. Meeting Date: January 5, 2024
2. Meeting place: Conference room on the third floor of the company
3. Meeting mode: to be held on site
4. Time and manner of giving notice of Board meeting: by written notice on January 3, 2024
5. Meeting Moderator: Mr. CAI Tiyuan, Chairman
6. Explanation of legality and compliance of the convening situation:
The convening and convening of this meeting are in accordance with the relevant provisions of the Company Law, relevant laws, administrative regulations and the Articles of Association.
(2) Attendance at the meeting
The meeting shall be attended by 5 directors and shall be attended and authorized by 5 directors.

 

2. Deliberation of bills
(1) Deliberating and adopting the motion on the Company Providing Guarantees for the loans of wholly-owned subsidiary Banks
1. Contents of the motion:
Hunchun Deren Pharmaceutical Co., LTD., a wholly-owned subsidiary of the company, intends to sign a loan contract with Industrial Bank Co., LTD. Jilin Branch. The loan amount is expected to be no more than RMB 5 million and the loan term is no more than one year. The hospital receivables are used as the source of repayment, and Jilin Tianzheng Biotechnology Co., Ltd. provides guarantee for it (the specific guarantee is subject to the contract signed).
2. Motion voting result: 5 votes agreed; Zero votes against; There were zero abstentions.
3. Avoidance of voting:
None.
4. Submission to shareholders' meeting for voting:
This motion does not need to be submitted to the General meeting for consideration.

 

3. File directory for reference
Resolution of the Second Meeting of the Fourth Board of Directors of Jilin Tianzheng Biotechnology Co., LTD

 

 

 

Jilin Tianzheng Biotechnology Co., LTD
Board of directors
January 5, 2024